| Financial Year |
March 31 2023 |
| Monetary Funds |
615,367,977.46 |
| Held-for-trading Financial Assets |
85,791,776.87 |
| Notes Receivable |
117,855,101.61 |
| Accounts Receivable |
956,863,074.41 |
| Advances to Suppliers |
38,748,881.55 |
| Other Receivables |
48,791,038.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
630,838,732.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
98,838,265.60 |
| Total Current Assets |
2,981,951,635.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,527,386.90 |
| Investment Properties |
28,603,671.21 |
| Fixed Assetes |
1,267,138,597.72 |
| Under-construction Projects |
105,646,164.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
476,580,514.90 |
| R&D expenses |
-- |
| Goodwill |
27,436,768.90 |
| Long-Term Deferred and Prepaid Expenses |
4,788,113.48 |
| Deferred Income Tax Assets |
82,067,359.13 |
| Other Non-Current Assets |
35,162,326.66 |
| Sub-Total of Non-Current Assets |
3,639,668,952.62 |
| Total Assets |
6,621,620,588.52 |
| Short-Term Loans |
1,058,231,204.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
235,499,628.33 |
| Accounts Payable |
770,185,019.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,451,436.61 |
| Taxes Payable |
40,381,895.53 |
| Interest Payable |
-- |
| Dividend Payable |
399,881.72 |
| Other payables |
42,832,368.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
296,771,822.88 |
| Other Current Liabilities |
97,944,759.95 |
| Sub-Total of Current Liabilities |
2,722,266,344.23 |
| Long-term Loans |
26,799,584.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
35,894,265.67 |
| Deferred Income Tax Liabilities |
204,066,008.54 |
| Other Non-Current Liabilities |
84,953,604.89 |
| Sub-Total of Non-Current Liabilities |
391,280,992.99 |
| Total Liabilities |
3,113,547,337.22 |
| Paid-In Capital(Or Share Stock) |
787,791,994.00 |
| Capital Surplus |
1,586,885,665.13 |
| Surplus Reserve |
166,462,850.77 |
| LESS:Treasury Stock |
84,953,604.89 |
| Undistributed Profits |
925,828,796.78 |
| Minority Stockholder's Interest |
100,879,402.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,407,193,849.29 |
| Owner's Equity（Stockholder's Equity） |
3,508,073,251.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,621,620,588.52 |
